Elon Musk's years-long legal battle with OpenAI and Sam Altman will finally head to trial on Monday

Elon Musk’s lawsuit against OpenAI goes to trial Monday, with jury selection beginning in US District Court for the Northern District of California and opening arguments expected Tuesday. The case centers on allegations that OpenAI misled Musk about its shift from nonprofit to for-profit, a dispute that could affect OpenAI’s future IPO plans and potentially force a rollback of its transition. OpenAI’s most recent fundraising valued the company at $852 billion, and the trial is expected to run through mid-May.

Analysis

The market is likely underpricing how much this case is really about governance leverage, not just legal liability. Even a nonbinding plaintiff win creates a credible path to remedial delay, capital-structure complexity, and a longer-dated overhang on any monetization event that depends on clean corporate form; that matters more for valuation than the headline legal outcome. For MSFT, the issue is not direct damages so much as the possibility that its embedded option on OpenAI economics becomes less liquid and more politically constrained if the structure is challenged.

The second-order effect is on the AI funding stack. If OpenAI’s path to external capital becomes noisier, the marginal beneficiary is likely the broader private AI ecosystem where investors can still underwrite growth without a binary governance overhang; the loser is the “winner-take-most” premium embedded in late-stage frontier-model names. That also feeds back into compute demand: any delay in financing can ripple into capex pacing at the hyperscalers, which could compress near-term enthusiasm for the AI infrastructure trade even if long-run demand remains intact.

For TSLA, the direct earnings linkage is limited, but the legal narrative matters because it keeps Musk’s attention and public conflict centered on a competitive arena where Tesla has no clean strategic advantage. The more important angle is distraction and optionality: if the dispute becomes a multi-month media and courtroom cycle, it can anchor volatility around Musk-related assets and create repeated event-risk bursts rather than a one-time repricing. The market should treat this as a low-probability, high-conviction tail event with a surprisingly long second-order path if remedies are even partially imposed.

The contrarian view is that the consensus may be overweighting the “OpenAI IPO delay” angle and underweighting the probability of a negotiated structural outcome after the first adverse signals. Courts often push parties toward economic settlements, and that could preserve most of the enterprise value while still creating enough governance friction to cap upside. In that scenario, the best trade is not a directional collapse in AI names, but a volatility expression around the legal calendar.

Key Decisions for Investors

• Buy MSFT downside protection into jury selection: 1-3 month put spread, targeting a modest negative drift rather than a collapse; best risk/reward if the market starts pricing remedial delay or governance headlines.
• Short a basket of late-stage private AI proxies against long diversified hyperscalers over the next 4-8 weeks: express as long MSFT / short a basket of unlisted or proxy AI winners where valuation depends on clean IPO optionality.
• For TSLA, use event-driven options rather than outright equity: buy a short-dated straddle around key testimony dates if implied volatility is below realized; this is a volatility catalyst, not a clean directional signal.
• If OpenAI governance headlines worsen, add to infrastructure beneficiaries with less legal overhang on a 3-6 month horizon; the cleaner trade is long compute enablers versus frontier-model optionality.
• Avoid chasing a large directional short in MSFT or TSLA pre-verdict; the more attractive setup is to scale in after the first court-generated signal, when the market can better distinguish delay risk from structural impairment.